PSA Test Might Predict Which Men Will Have Low Risk Prostate Cancer

The PSA test may be valuable in predicting which men should have biopsies and which are likely to be diagnosed with low risk prostate cancer, according to a new Mayo Clinic study.  John Schieszer reports in today’s Medical Minute that researchers have found a clear link between the PSA test and the next steps in the prostate cancer continuum of care.